StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
OSURORASURE TECHNOLOGIES INC
stockpulse.co.kr
Nasdaq
$4.07▼ 1.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $280.2MShares out 68.8M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 10.1After-hours26.10.02 05:25
    4Ownership#●●●

    ORASURE TECHNOLOGIES INC

    Steven Kyle Boyd, an insider at OraSure Technologies (OSUR), filed a Form 4 statement of changes in beneficial ownership of securities on September 29, 2026. This filing officially reports the change in the insider's equity holdings.…more

    $4.07-1.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.18Overnight26.09.18 09:08
    SCHEDULE 13DOwnership

    ORASURE TECHNOLOGIES INC

    Yorkville Advisors and Islet Management have formed a group to enhance shareholder value at OraSure Technologies, including the potential nomination of directors for the 2027 annual meeting. The parties have agreed to coordinate their share purchases and actions, and will file joint SEC disclosures as required.…more

    $4.07-1.09%vs prev close
    View filingShare
  • 9.9After-hours26.09.10 05:12
    4Ownership

    ORASURE TECHNOLOGIES INC

    John P. Kenny, a director of OraSure Technologies, Inc. (OSUR), reported a change in his beneficial ownership of company securities effective September 6, 2026. This filing serves as a standard Form 4 disclosure regarding director stock holdings.…more

    $4.07-1.09%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 8.5After-hours26.08.06 05:05
    Bullish#●●●#●●●#●●●

    오라슈어, 2분기 매출 가이던스 상회 및 FDA 승인 성과

    오라슈어는 2분기 매출 3,060만 달러를 기록하며 가이던스 범위를 상회하는 실적을 달성했습니다. 최근 성병 진단 키트와 에볼라 신속 진단 키트에 대한 FDA 승인을 획득하며 진단 사업 부문의 혁신을 이어가고 있습니다.…more

    $4.07-1.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 7.22After-hours26.07.23 05:10

    ●●●●●●●● ●●●●● ●●●●●●

    오라슈어 테크놀로지스는 8월 5일 장 마감 후 2026년 2분기 실적을 발표하고 컨퍼런스 콜을 개최할 예정입니다. 이는 투자자들에게 회사의 재무 성과와 향후 전망을 파악할 기회를 제공합니다.…more

    $4.07-1.09%vs prev close
    Read sourceShareGlobeNewswire
  • 7.21After-hours26.07.22 05:30

    ●●●●●●●● ●●●●● ●●●●●●

    오라슈어 테크놀로지스가 2세대 에볼라 신속 항원 진단키트 'OraQuick™ Ebola 2.0'에 대해 미국 FDA 긴급사용승인(EUA)을 획득했습니다. 이 진단키트는 현재 아프리카에서 확산 중인 부츈디부고 바이러스를 포함한 4종의 에볼라 바이러스를 탐지하며, 환자 및 사망자 진단에 활용될 예정입니다.…more

    $4.07-1.09%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →